Dare Bioscience Investor Presentation Deck

Management Team Sabrina Martucci Johnson, MSc, MIM President & CEO John Fair Chief Strategy Officer Experienced Management & Board of Directors Lisa Walters-Hoffert Chief Financial Officer David Friend, PhD Chief Scientific Officer Christine Mauck, MD, MPH Medical Director Annie Thurman, MD, FACOG Medical Director Mark Walters Vice President of Operations Board of Directors William Rastetter, PhD Chairman Cheryl Blanchard, PhD Jessica Grossman, MD ROTH Capital te Susan Kelley, MD ADVANCED TISSUE receptos Bank of America BAYER Bayer SCIENCES biogen idec dentsu AEGIS network Johnson Johnson Medicines 360 Cooper Companies Cypress mone The Sophia Consulting Firm Agilent Technologies (AHP) lli Bristol Myers Squibb elan GRAIL hp microchips BIOTECH Skyepharma HEWLETT PACKARD Greg Matz, CPA SRI International Sophia N. Ononye-Onyia, PhD, MPH, MBA Robin Steele, JD, LLM Sabrina Martucci Johnson, MSc, MIM President & CEO Alios BioPharma Calibr at Scripps Research IgGenix Neurocrine PPENHEIMER FDA U.S. FOOD & DRUG ADMINISTRATION ARQULE We are delivering innovation by daring to be differentⓇ Citi illumina Baxter CONRAD Leaders in Reductive Health and HDV Prev Pfizer PACIRA Wyeth INTERMUNE POPULATION COUNCIL Ideas, Evidence. Impact. ZIMMER BIOMET Your progress. Our promise 13

View entire presentation